Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,412 | -42,077 | 121,190 | 4,058 | 32,252 |
| Depreciation Amortization | 50 | 7 | 29 | 22 | 15 |
| Accounts receivable | N/A | N/A | N/A | N/A | -50,000 |
| Accounts payable and accrued liabilities | 9,351 | -877 | 10,289 | 27,945 | 16,456 |
| Other Working Capital | -28,402 | -28,616 | -247,845 | -43,932 | -83,732 |
| Other Operating Activity | 14,218 | 12,554 | 29,332 | 325 | 50,824 |
| Operating Cash Flow | $-78,195 | $-59,009 | $-87,005 | $-11,582 | $-34,185 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,923 | -44 | -4 | N/A | N/A |
| Investing Cash Flow | $-1,923 | $-44 | $-4 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 223 | 223 | 1,465 | 1,323 | 528 |
| Financing Cash Flow | $223 | $223 | $1,465 | $1,323 | $528 |
| Beginning Cash Position | 764,680 | 764,680 | 850,224 | 850,224 | 850,224 |
| End Cash Position | 684,785 | 705,850 | 764,680 | 839,965 | 816,567 |
| Net Cash Flow | $-79,895 | $-58,830 | $-85,544 | $-10,259 | $-33,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,195 | -59,009 | -87,005 | -11,582 | -34,185 |
| Capital Expenditure | -1,923 | -44 | -4 | N/A | N/A |
| Free Cash Flow | -80,118 | -59,053 | -87,009 | -11,582 | -34,185 |